Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.68% | -23.78% | -35.82% | -61.99% | -54.54% |
| Total Depreciation and Amortization | -9.94% | -10.24% | -9.08% | -8.03% | -5.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.68% | 4.18% | 59.60% | 143.99% | 146.82% |
| Change in Net Operating Assets | -730.57% | -605.59% | -460.10% | -55.64% | 116.66% |
| Cash from Operations | -37.31% | -37.70% | -48.92% | -42.76% | -25.54% |
| Capital Expenditure | -21.34% | -83.64% | -152.00% | -128.70% | -139.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | -11.97% | -95.76% | -168.00% | -146.09% | -159.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -54.64% | -96.30% | -84.47% | 3.29% | 8,080.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 79.72% | -- | 73.42% | 98.92% |
| Cash from Financing | -54.64% | -96.34% | -84.43% | 3.56% | 4,073.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.90% | -160.38% | -150.63% | -43.52% | 346.24% |